Drug Information

Drug General Information
Drug ID
D08FKH
Former ID
DIB014322
Drug Name
KLH-2109
Indication Endometriosis [ICD9: 617; ICD10:N80] Phase 2 [523797]
Company
Kissei Pharmaceutical Co Ltd
Target and Pathway
Target(s) Gonadotropin-releasing hormone receptor Target Info Agonist [550310]
KEGG Pathway Neuroactive ligand-receptor interaction
GnRH signaling pathway
NetPath Pathway IL1 Signaling Pathway
IL2 Signaling Pathway
PANTHER Pathway Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway
Reactome Hormone ligand-binding receptors
G alpha (q) signalling events
WikiPathways Gastrin-CREB signalling pathway via PKC and MAPK
Peptide GPCRs
GPCR ligand binding
GPCR downstream signaling
GPCRs, Other
References
Ref 523797ClinicalTrials.gov (NCT01533532) A Randomized, Placebo-controlled, Double-blind Study of KLH-2109 in Patients With Endometriosis (2). U.S. National Institutes of Health.
Ref 550310Clinical pipeline report, company report or official report of Avarx.

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.